AWSCX
Price
$16.31
Change
+$0.09 (+0.55%)
Updated
Jul 31 closing price
Net Assets
652.94M
CWGCX
Price
$79.77
Change
+$0.71 (+0.90%)
Updated
Jul 31 closing price
Net Assets
157.74B
Interact to see
Advertisement

AWSCX vs CWGCX

AWSCX vs CWGCX Comparison Chart in %
View a ticker or compare two or three
VS
AWSCX vs. CWGCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWSCX is a Buy and CWGCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 158B vs. AWSCX (653M). CWGCX (0.72) and AWSCX (0.71) have matching dividends . AWSCX was incepted earlier than CWGCX: AWSCX (26 years) vs CWGCX (25 years). AWSCX (2.00) is less costly to investors than CWGCX (1.48). AWSCX is a more actively managed with annual turnover of: 80.00 vs. CWGCX (44.00). CWGCX has a lower initial minimum investment than AWSCX: CWGCX (250) vs AWSCX (1000). CWGCX annual gain was more profitable for investors over the last year : 14.67 vs. AWSCX (6.26). CWGCX return over 5 years is better than : 29.13 vs. AWSCX (5.13).
AWSCXCWGCXAWSCX / CWGCX
Total Expense Ratio2.001.48135%
Annual Report Gross Expense Ratio2.001.48135%
Fund Existence26 years25 years-
Gain YTD10.42713.54977%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets653M158B0%
Annual Yield % from dividends0.710.7298%
Returns for 1 year6.2614.6743%
Returns for 3 years28.4940.8370%
Returns for 5 years5.1329.1318%
Returns for 10 years26.2187.4330%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EEMFX12.120.26
+2.19%
MFS Emerging Markets Equity Research R3
TICRX26.140.25
+0.97%
Nuveen Large Cap Responsible Eq A
BDHCX9.030.07
+0.82%
BlackRock Dynamic High Income Inv C
SSIPX16.22-0.10
-0.61%
State Street International Stock Sel I
FILRX17.18-0.18
-1.04%
Franklin Intl Growth R6